Chicago Tribune - The Whitehouse Station, N.J.-based maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies reported net income of $1.53 billion, or 70 cents a share, up from $940.6 million, or 43 cents a share, a year earlier. Revenue climbed ...
